Clinical Trials Logo
  1. Home
  2. Albuminuria
  3. NCT04626271

Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User Hands

Albuminuria Clinical Trial

Official title:
Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User Hands

Clinical Trial Summary

Eligible subjects meeting the pathological profile will be recruited at the designated site by the study personnel. Following subject consent, the subjects will be evaluated for eligibility based on their health condition and history. The ACR | U.S. kit, in its original packaging, along with the ACR | U.S. smartphone application will be provided to the subject in a simulated home- use environment. All subjects will be provided with a list of tasks to complete, including providing a urine sample and operating the ACR | U.S. device on 2 mobile phones. After completing the test, the lay user will complete a post-test questionnaire. The study observer will also complete a questionnaire to collect information regarding the lay users' use of the ACR | U.S. The device use will be compared with identified risks to determine if the percentage of failures is acceptable. Additionally, measurable usability criteria for specific, critical steps will be evaluated. Following the usability test performed by the lay user, the subjects' urine samples will be tested by the study staff using the comparator device. These results will be considered as the "true value".

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04626271
Study type Interventional
Source Healthy.io Ltd.
Contact
Status Completed
Phase N/A
Start date August 31, 2020
Completion date October 25, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT00095290 - Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria Phase 4
Completed NCT02144740 - Effect of NWT-03 on Blood Pressure N/A
Completed NCT01041599 - Correlation of Albuminuria With Arterial Stiffness N/A
Active, not recruiting NCT05321095 - Screening for Albuminuria at the First Line for Early Identification of CKD
Completed NCT02945969 - Sodium Lowering and Urinary Protein Reduction Trial Phase 3
Enrolling by invitation NCT04295889 - Towards HOMe-based Albuminuria Screening: an Implementation Study Testing Two Approaches N/A
Recruiting NCT04272359 - Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus
Completed NCT03889236 - Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy. N/A
Active, not recruiting NCT00625820 - Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria Phase 2
Recruiting NCT04752293 - Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Completed NCT03118739 - Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria Phase 2
Completed NCT06374043 - Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin. Phase 4
Completed NCT03396328 - Effects of Intensive Low-Salt Diet Education by Mobile Application on Albuminuria N/A
Not yet recruiting NCT06094920 - Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial Phase 4
Recruiting NCT00342927 - Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Completed NCT02689778 - Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy Phase 3
Completed NCT02497300 - Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease Phase 2
Completed NCT02446548 - Influence of Aliskiren on Albuminuria After Kidney Transplantation N/A
Completed NCT01547897 - NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria Phase 2
Enrolling by invitation NCT01316068 - Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients Phase 4